This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Mark Prichard: Innovator in HSV-2 Treatment
Introduction
Mark Prichard is a notable inventor based in Birmingham, AL (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of HSV-2 infections. His innovative work has the potential to impact many lives.
Latest Patents
Mark Prichard holds 1 patent for his invention titled "Methods and compositions for treatment and prevention of HSV-2 infections." This patent involves live, attenuated, phenotypically stable HSV-2 viruses and methods for their production and use. The recombinant techniques used to construct these viruses allow for their application in pharmaceutical compositions aimed at both prophylactic treatment and the management of recurrent HSV-2 related diseases and conditions.
Career Highlights
Mark Prichard is associated with Medimmune Limited, where he continues to advance his research and development efforts. His work is crucial in the ongoing battle against viral infections, particularly those caused by HSV-2.
Collaborations
Throughout his career, Mark has collaborated with esteemed colleagues such as Richard R. Spaete and George William Kemble. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Mark Prichard's contributions to the field of HSV-2 treatment exemplify the impact of innovative thinking in medical science. His work not only advances our understanding of viral infections but also offers hope for effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile